세계의 항우울제 시장 규모 조사 : 제품별, 우울장애별, 지역별 예측(2022-2032년)

Global Antidepressant Drugs Market is valued approximately USD 17 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 3.0% over the forecast period 2024-2032. Antidepressants are a type of medication used to treat depression, a condition that causes persistent feelings of sadness and a loss of interest in activities you once enjoyed. They can also be helpful for other conditions such as anxiety and obsessive-compulsive disorder. Additionally, a variety of disorders, including post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), and generalized anxiety disorder, are treated with these medications. Chronic pain sufferers are also treated with it. Prescription antidepressants can be used alone or in combination with behavioural therapy and physical activity as a first-line treatment for depression. Furthermore, rising investment in development of Antidepressant Drugs and rising awareness of disease prevalence among people are gaining attention towards Global Antidepressant Drugs Market.

The Global Antidepressant Drugs Market is driven by the rise in awareness regarding depression, increasing prevalence of depression, and advancements in research and development activities in the healthcare sector across the globe. According to the World Health Organization (WHO), in year 2021, around 5% of the adult are diagnose with depression. Antidepressant drugs maintain balance of various hormones and chemicals in the brain. Moreover, rising prevalence of life-threatening diseases such as obsessive-compulsive disorder, major depressive disorder generalized anxiety disorder is driving the marker growth. Moreover, rise in geriatric population and, increase in number of approvals for the development of antidepressant drugs is creating new opportunities to the market. However, side effects associated with drug and strict regulatory compliance is going to impede the overall demand for the market during the forecast period 2024-2032.

The key regions considered for the Global Antidepressant Drugs market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America was the largest regional market in terms of revenue owing to rising prevalence of depression disorder, increasing number of drug approval, presence of key market players, and rise in initiatives for the development and investment in R&D activities in the healthcare sector in region. However, Asia-Pacific is expected to register fastest growth owing to factors such as increase in prevalence of mental disorders, rise in awareness regarding depression, growth in health care expenditures, and increase in number of clinical trials are some factors which are expected to develop the region at the fastest rate over the forecast period 2024-2032.

Major market player included in this report are:

• Alkermes Plc
• AbbVie Inc.
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline, Inc.
• H. Lundbeck A/S
• Merck KGAA
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd. (Actavis Generics)
• Takeda Pharmaceutical Limited Company

The detailed segments and sub-segment of the market are explained below:

By Product

• Tricyclic Antidepressants
• Selective Serotonin Reuptake Inhibitors
• Serotonin Norepinephrine Reuptake Inhibitors
• Monoamine Oxidase Inhibitors
• Serotonin Antagonist and Reuptake Inhibitors
• Others

By Depressive Disorders

• Major Depressive Disorder
• Obsessive-Compulsive Disorder
• Generalized Anxiety Disorder
• Panic Disorder
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market

Table of Contents

Chapter 1. Global Antidepressant Drugs Market Definition and Research Assumptions

• 1.1. Research Objective
• 1.2. Market Definition
• 1.3. Research Assumptions
  • 1.3.1. Inclusion & Exclusion
  • 1.3.2. Limitations
  • 1.3.3. Supply Side Analysis
    • 1.3.3.1. Availability
    • 1.3.3.2. Infrastructure
    • 1.3.3.3. Regulatory Environment
    • 1.3.3.4. Market Competition
    • 1.3.3.5. Economic Viability (Consumer's Perspective)
  • 1.3.4. Demand Side Analysis
    • 1.3.4.1. Regulatory frameworks
    • 1.3.4.2. Technological Advancements
    • 1.3.4.3. Environmental Considerations
    • 1.3.4.4. Consumer Awareness & Acceptance
• 1.4. Estimation Methodology
• 1.5. Years Considered for the Study
• 1.6. Currency Conversion Rates

Chapter 2. Executive Summary

• 2.1. Global Antidepressant Drugs Market Size & Forecast (2022- 2032)
• 2.2. Regional Summary
• 2.3. Segmental Summary
  • 2.3.1. By Product
  • 2.3.2. By Depressive Disorder
• 2.4. Key Trends
• 2.5. Recession Impact
• 2.6. Analyst Recommendation & Conclusion

Chapter 3. Global Antidepressant Drugs Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Challenges
• 3.3. Market Opportunities

Chapter 4. Global Antidepressant Drugs Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top investment opportunity
• 4.4. Top winning strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Antidepressant Drugs Market Size & Forecasts by Product 2022-2032

• 5.1. Tricyclic Antidepressants
• 5.2. Selective Serotonin Reuptake Inhibitors
• 5.3. Serotonin Norepinephrine Reuptake Inhibitors
• 5.4. Monoamine Oxidase Inhibitors
• 5.5. Serotonin Antagonist and Reuptake Inhibitors
• 5.6. Others

Chapter 6. Global Antidepressant Drugs Market Size & Forecasts by Depressive Disorder 2022-2032

• 6.1. Major Depressive Disorder
• 6.2. Obsessive-Compulsive Disorder
• 6.3. Generalized Anxiety Disorder
• 6.4. Panic Disorder
• 6.5. Others

Chapter 7. Global Antidepressant Drugs Market Size & Forecasts by Region 2022-2032

• 7.1. North America Antidepressant Drugs Market
  • 7.1.1. U.S. Antidepressant Drugs Market
    • 7.1.1.1. Product breakdown size & forecasts, 2022-2032
    • 7.1.1.2. Depressive Disorder breakdown size & forecasts, 2022-2032
  • 7.1.2. Canada Antidepressant Drugs Market
• 7.2. Europe Antidepressant Drugs Market
  • 7.2.1. U.K. Antidepressant Drugs Market
  • 7.2.2. Germany Antidepressant Drugs Market
  • 7.2.3. France Antidepressant Drugs Market
  • 7.2.4. Spain Antidepressant Drugs Market
  • 7.2.5. Italy Antidepressant Drugs Market
  • 7.2.6. Rest of Europe Antidepressant Drugs Market
• 7.3. Asia-Pacific Antidepressant Drugs Market
  • 7.3.1. China Antidepressant Drugs Market
  • 7.3.2. India Antidepressant Drugs Market
  • 7.3.3. Japan Antidepressant Drugs Market
  • 7.3.4. Australia Antidepressant Drugs Market
  • 7.3.5. South Korea Antidepressant Drugs Market
  • 7.3.6. Rest of Asia Pacific Antidepressant Drugs Market
• 7.4. Latin America Antidepressant Drugs Market
  • 7.4.1. Brazil Antidepressant Drugs Market
  • 7.4.2. Mexico Antidepressant Drugs Market
  • 7.4.3. Rest of Latin America Antidepressant Drugs Market
• 7.5. Middle East & Africa Antidepressant Drugs Market
  • 7.5.1. Saudi Arabia Antidepressant Drugs Market
  • 7.5.2. South Africa Antidepressant Drugs Market
  • 7.5.3. Rest of Middle East & Africa Antidepressant Drugs Market

Chapter 8. Competitive Intelligence

• 8.1. Key Company SWOT Analysis
• 8.2. Top Market Strategies
• 8.3. Company Profiles
  • 8.3.1. Alkermes Plc
    • 8.3.1.1. Key Information
    • 8.3.1.2. Overview
    • 8.3.1.3. Financial (Subject to Data Availability)
    • 8.3.1.4. Product Summary
    • 8.3.1.5. Market Strategies
  • 8.3.2. AbbVie Inc.
  • 8.3.3. Eli Lilly and Company
  • 8.3.4. F. Hoffmann-La Roche Ltd.
  • 8.3.5. GlaxoSmithKline, Inc.
  • 8.3.6. H. Lundbeck A/S
  • 8.3.7. Merck KGAA
  • 8.3.8. Pfizer Inc.
  • 8.3.9. Teva Pharmaceutical Industries Ltd. (Actavis Generics)
  • 8.3.10. Takeda Pharmaceutical Limited Company

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes